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Abstract
Background: We report a case of bilateral central retinal artery occlusion and the evaluation of retinal vasculature
and capillaries by using optical coherence tomography angiography.
Case presentation: A 75-year-old white man presented with central retinal artery occlusion in one eye and
underwent a carotid angioplasty. Upon discontinuing anticoagulant, he had a subsequent central retinal artery
occlusion in the other eye. Optical coherence tomography angiography images were obtained to compare the
retinal microvasculature in both eyes.
Conclusions: Atrophy of the involved retina continues for several weeks after central retinal artery occlusion but
the loss of retinal capillaries is immediate and stable over time. The presence of cilioretinal arteries that perfuse the
central macula can prevent profound vision loss.
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Background
Central retinal artery occlusion (CRAO) is an important
vascular cause of serious vision loss. The incidence of
non-arteritic CRAO is estimated to be 1 in 100,000
people [1] and most result in profound vision loss [2].
Despite being a well-recognized ophthalmic emergency
[3], limited progress has been made in diagnostic evalua-
tions. Studies suggest that CRAO lasting approximately
240 minutes results in irreparable retinal damage [3, 4].
Fluorescein angiography (FA) has been a standard
method in assessing retinal vasculature and diseases
such as CRAO [5]. Sodium fluorescein is given intraven-
ously and the fluorescence emitted from retinal and
choroidal circulation is detected on angiography. CRAO
can be diagnosed clinically with common funduscopic
findings such as diffuse retinal edema, “cherry-red spot,”
“box-carring,” or attenuation of the vessels [6, 7]. The
delayed filling of the affected vessels on FA confirms the
diagnosis. However, FA is invasive and relatively contra-
indicated in pregnancy or chronic kidney failure. In
addition, the visualizations of retinal vasculature are lim-
ited with this imaging [5]. Recently, the introduction of
optical coherence tomography angiography (OCTA) has
shown promising results in allowing noninvasive func-
tional imaging of retinal vasculature [8]. With this im-
aging modality, both structural and functional changes
of the retina can be assessed.
Optical coherence tomography-based microangiography
(OMAG) is an OCTA algorithm and has been used for
evaluation of various retinal diseases [9, 10]. With this
technology, the retinal microvasculature can be visualized,
quantified, and dissected in various layers. There has been
increasing interest in evaluating the area of retinal ische-
mia following retinal arterial occlusions using structural
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images of spectral domain OCT (SD-OCT) without the
angiography component [5, 11]. Using OMAG, the super-
ficial, intermediate, and deeper retinal capillary plexus can
be visualized in vivo in addition to structural images. The
purpose of this case report is to describe key retinal struc-
ture changes and vasculature findings in a case of bilateral
CRAOs using fundus photo, SD-OCT, and OMAG.
Case presentation
Clinical details
A 75-year-old white man with a history of ischemic car-
diomyopathy status post-heart transplant presented with
acute loss of vision in his right eye for 1 week, no history
of polymyalgia rheumatica, and no scalp tenderness, jaw
claudication, proximal muscle weakness, or temporal
headache. His best-corrected visual acuity was 20/25
eccentrically in his right eye and 20/25 in his left eye.
Fundus imaging showed several Hollenhorst plaques and
diffuse whitening of his retina except for the nasal
macula (Fig. 1a). FA was not obtained due to severe
chronic renal insufficiency.
He underwent a stroke workup including a complete
blood count (CBC), erythrocyte sedimentation rate
(ESR), C-reactive protein (CRP), carotid Doppler, echo-
cardiogram, and magnetic resonance imaging/angiog-
raphy (MRI/MRA) of his brain. Of note, his platelet
count was 148×103/uL, ESR 21, and CRP was 7.4 mg/L.
An approximate 90 % stenosis at the origin of his
innominate artery with 30 % stenosis of the right
carotid bulb was found. He underwent balloon angio-
plasty and stenting of his innominate artery and was
placed on a daily dose of aspirin (325 mg) and clopido-
grel (75 mg); however, he stopped the medicine due to
poor tolerance.
Four months after the CRAO in his right eye and a few
weeks after discontinuing clopidogrel, he had another
episode of acute painless vision loss involving his left, pre-
viously unaffected, eye. At this time, his visual acuity was
20/30 eccentrically in his right eye and 20/400 in his left
eye. A funduscopic examination 4 days after the episode
of his left eye revealed diffuse whitening of his retina with
a cherry red spot (Fig. 1b). A repeat workup was unre-
markable and he was restarted on clopidogrel. Fundus
photographs were repeated three months after the CRAO
in each eye (Fig. 1c, d).
Investigations
He underwent a comprehensive ophthalmologic examin-
ation and color fundus imaging (Topcon, Tokyo, Japan)
tests and SD-OCT imaging (Heidelberg, Heidelberg,
Germany) tests whenever possible during his initial visit
and follow-up visits. In addition, OMAG imaging was
obtained subsequently using a modified SD-OCT
(CIRRUS prototype provided by Carl Zeiss Meditec
Inc., Dublin, CA, USA) with a central wavelength of
850 nm and a speed of 100,000 A-scans per second.
The details of OMAG scanning protocol and algorithm
have been described previously [9]. The complex version
Fig. 1 Fundus color photographs of both eyes. a One week after foveal-sparing central retinal artery occlusion in the right eye, diffuse macular edema
is present except for nasal parafovea and perifovea. Hollenhorst plaque is noted. b Four days after the central retinal artery occlusion in the left eye,
diffuse macular edema is noted with cherry red spot. The nasal and temporal peripapillary retina are unaffected. c Three months after the central retinal
artery occlusion in the right there is attenuation of the arterioles. d Three months after the central retinal artery occlusion in the left eye
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of the OMAG algorithm was applied to the images that
were extracted. The retinal images were segmented into
three different retinal layers using a semi-automated algo-
rithm: an inner retinal layer from the ganglion cell layer to
the inner plexiform layer, a middle retinal layer from the
inner nuclear layer to the outer plexiform layer, and an
outer retinal layer from the external limiting membrane
and the outer nuclear layer. The three-dimensional struc-
ture of the retina was projected using Matlab (The Math-
Works, Inc., Natick, MA, USA).
The mean retinal thickness was measured by calculat-
ing the average of five consecutive scans. The macula
was divided into nine zone Early Treatment Diabetic
Retinopathy Study (ETDRS) grids: parafovea, inner/outer
nasal, inner/outer temporal, inner/outer superior, and
inner/outer inferior. Perfusion index was defined as the
percent coverage of the area by retinal vessels with flow.
For his right eye, the perfusion indices were compared
between two subsequent visits following the foveal-
sparing CRAO. For his left eye, the perfusion indices
before and after CRAO were compared.
SD-OCT imaging was obtained at 1, 3, 5, and 7
months after the foveal-sparing CRAO in his right eye
(Fig. 2a–d). Both superficial and deep retinal layer thick-
ness decreased in the involved temporal macula com-
pared to the nasal macula. Mean retinal thickness
temporal to fovea (500 μm away from the foveal center)
in his right eye at months 1, 3, 5, and 7 was 250 μm, 204
μm, 194 μm, and 191 μm, respectively. OMAG images of
his right eye at 1 and 3 months are shown in Fig. 3a, c.
OMAG images of his left eye prior to the CRAO and 1
month after the CRAO are shown In Fig. 3b, d.
SD-OCT imaging was obtained on day 4 and at 1
month, 3 months, and 5 months after the CRAO in his
left eye. (Fig. 2e–h) On day 4, there was diffuse edema
involving both superficial and deep retinal layers. Mean
retinal thickness temporal to fovea (660 μm away from
the foveal center) was 504 μm. Follow-up images of the
same area revealed thicknesses of 246 μm, 215 μm, and
196 μm, at months 1, 3, and 5, respectively.
Perfusion indices showed no significant difference
during two consecutive visits after the CRAO in his right
eye (Fig. 4). The perfusion indices in all zones were
below 40 except for the inner and outer nasal ETDRS
zones which were unaffected by the CRAO. There was a
statistically significant difference in the perfusion indices
of all nine zones before and after the CRAO in his left
eye (p-value <0.001, Fig. 4). The average perfusion index
in the eight non-central zones prior to the CRAO
was 40 (range 39 to 45) while the average perfusion
index after the CRAO in the non-central zones was
20 (range 10 to 30).
Outcomes
The retinal vasculature loss following CRAO was acute
and permanent, but the retinal atrophy progressed over
several months. In our patient, the thickness of inner
retina continued to decrease until month 5, but then it
stabilized on follow-up visits. However, the structural
architecture of nasal retina remained undisrupted by
SD-OCT throughout the follow-up period. OMAG
images showed severe loss of all retinal microvasculature
involving intermediate and deep plexus more than the
superficial plexus. The en face OMAG images ob-
tained at months 1 and 3 demonstrated visible absence
of the retinal microvasculature in his right eye except
for the nasal macula (Fig. 3a, c). The en face OMAG
image obtained at month 1 after the CRAO in the left
Fig. 2 Spectral domain optical coherence tomography of both eyes. a–d Spectral domain optical coherence tomography of the right eye
obtained at 1, 3, 5, and 7 months respectively after the central retinal artery occlusion. e–h. Spectral domain optical coherence tomography of
the left eye obtained 4 days, 1 month, 3 months, and 5 months respectively after the central retinal artery occlusion
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eye revealed loss of retinal capillary plexus in the
entire macula (Fig. 3d).
Even though the FA is a standard imaging modality in
evaluating retinal vascular diseases, FA is often not pos-
sible due to time commitment and patient factors such
as renal insufficiency. Although FA would have been
diagnostic in our patient, it was deferred due to chronic
renal insufficiency. Contraindications for FA include
fluorescein allergy, renal failure, pregnancy, moderate-
severe asthma, and significant cardiac cases [12]. The
noninvasive nature of OCTA is advantageous in many of
our patients with multiple comorbidities. In addition,
the image quality can vary due to media opacity such as
cataract and patient cooperation. Smaller capillaries and
deeper retinal plexus are not visible with FA. In contrast,
OCTA provides a safe and potentially superior alterna-
tive method of assessing total retinal vasculature.
Recently, retinal artery occlusions were characterized as
superficial and/or intermediate and deep capillary plexus
ischemia using SD-OCT images [11]. In particular, the
ischemia within the intermediate and deeper retinal capil-
lary plexus were described as a hyper-reflective lesion at the
level of the inner nuclear layer and referred to as
paracentral acute middle maculopathy [13]. The character-
istic ischemia in the inner retina cannot be presumed based
only on the change in the reflective pattern seen on SD-
OCT, but OCTA allows for direct visualization of perfusion
and quantification. Thus, the vascular change evident on
OCTA such as OMAG could become an important clinical
endpoint in future studies.
Our patient had extensive involvement of all three retinal
capillary plexuses. In particular, the loss of vasculature in
the deep capillary plexus appeared more profound in the is-
chemic areas compared to the perfused nasal retina sup-
plied by the cilioretinal artery in both eyes. Unfortunately,
the cilioretinal artery of our patient’s left eye did not supply
the fovea, thus he had more profound vision loss in this eye.
The presence of cilioretinal arteries that contribute to the
macula has been previously reported in 18.7 % of patients
[14], but there is high variability in the number, vessel cali-
ber, and location of cilioretinal arteries in the general public.
Perfusion indices are potentially objective values that
can be followed over time. These values can be inter-
preted as the areas of significant flow and low numbers
would indicate either decreased flow or area of ischemia.
In our analysis, the perfusion index was calculated using
Fig. 3 Optical coherence tomography-based microangiography images of both eyes. a Enface image obtained at 1 month after central retinal artery
occlusion in the right eye. b The optical coherence tomography-based microangiography image of the left eye prior to the central retinal artery
occlusion in the left eye. c Enface image obtained at 3 months after central retinal artery occlusion in the right eye. No significant difference is shown
between the enface images obtained 1 and 3 months after the central retinal artery occlusion in the right eye. d One month after the central retinal
artery occlusion in the left eye, diffuse loss of microvasculature is shown. Color schemes are based on the anatomical depth with green color being the
most superficial followed by yellow and red
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the perfusion percentage within independently subsam-
pled areas of the retina. This method allowed the quanti-
fication of the OCTA signal per each ETDRS zone
leading to a more robust quantification.
To the best of our knowledge, this is the first descrip-
tion of OCTA imaging in bilateral CRAO and compari-
son of the OCTA imaging before and after CRAO.
OCTA provides important information regarding vascu-
lar changes including hypoperfusion, ischemia, and ab-
normal structure. However, the lack of standardizations,
the lack of full understanding of the artifacts, and the
lack of large trials to determine the clinical relevance of
image findings are the main current limitations. Despite
these challenges, OCTA such as OMAG will probably
become an effective adjunct modality in diagnosing and
following retinal vascular diseases.
Conclusions
CRAO is a relatively common sight-threatening condition.
Using OCTA, we demonstrate that the atrophy of the
involved retina continues for several weeks following
CRAO but the loss of retinal capillaries is immediate and
stable over time. The presence of cilioretinal arteries that
perfuse the central macula can prevent profound vision
loss.
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